Effect of dihydroartemisinin on the antioxidant capacity of P. falciparum-infected erythrocytes

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 34, Issue 4, 2003, Pages 744-750

  Ittarat, Wanida ^a,b   Sreepian, Apichai ^a   Srisarin, Apapan ^a   Pathepchotivong, Kritsana ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ARTEMISININ; BIOLOGICAL MARKER; CATALASE; DIHYDROARTEMISININ; DRUG METABOLITE; ENDOPEROXIDE; FREE RADICAL; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; PEROXIDE; SUPEROXIDE DISMUTASE;

ANTIMALARIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPLETION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; ERYTHROCYTE; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; MALARIA FALCIPARUM; NONHUMAN; OXIDATIVE STRESS; PLASMODIUM FALCIPARUM;

EID: 1842830040     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-6.
2. Areekul S, Churdchu K, Thanomsak W, Pattanamatum S, Suphadtanaphongs V, Pojjiaroenanant C. Superoxide dismutase and catalase activities of cultured erythrocytes infected with Plasmodium falciparum. Southeast Asian J Trop Med Public Health 1988; 601-7.
3. Asawamahasakda W, Ittarat I, Pu YM, Ziffer H, Meshnick SR. Reaction of antimalarial endoperoxides with specific parasite proteins. Antimicrob Agents Chemother 1994; 38: 1854-8.
4. Atamma H, Ginsburg H. The malaria parasite supplies glutathione to its host cell-investigation of glutathione transport and metabolism in human erythrocytes infected with Plasmodium falciparum. Eur J Biochem 1997; 250: 670-9.
5. Berman PA, Adams PA. Artemisinin enhances hemecatalysed oxidation of lipid membranes. Free Radic Biol Med 1997; 22: 1283-8.
6. Bhisutthibhan J, Pan XQ, Hossler PA, et al. The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin. J Biol Chem 1998; 273: 16192-8.
7. Bilmen, ST, Aksu TA, Gumuslu S, Korgun DK, Canatan D. Antioxidant capacity of G-6-PD-deficient erythrocytes. Clinica Chimica Acta 2001; 303: 83-6.
8. Butler AR, Gilbert BC, Hulme P, Irvine LR, Renton L, Whitwood AC. EPR evidence for the involvement of free radicals in the iron-catalysed decomposition of qinghaosu (artemisinin) and some derivatives; antimalarial action of some polycyclic endoperoxides. Free Radic Res 1998; 28: 471-6.
9. Das BS, Nanda NK. Evidence for erythrocyte lipid peroxidation in acute falciparum malaria. Trans R Soc Trop Med Hyg 1999; 93: 58-62.
10. Desjardins E, Canfield CJ, Hayne JD, Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 1979; 16: 710-8.
11. Fritsch B, Dieckmann A, Menz B, et al. Glutathione and peroxide metabolism in malaria-parasitized erythrocytes. Parasitol Res 1987; 73: 515-7.
12. Gamain B, Arnaud J, Favier A, Camus D, Dive D, Slomianny C. Increase in glutathione peroxidase activity in malaria parasite after selenium supplementation. Free Radic Biol Med 1996; 21: 559-65.
13. Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1980; 106: 207-12.
14. Griffiths MJ, Ndungu F, Baird KL, Muller DP, Marsh K, Newton CR. Oxidative stress and erythrocyte damage in Kenyan children with severe Plasmodium falciparum malaria. Br J Haematol 2001; 113: 486-91.
15. Jain SK, McVie R. Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients. Diabetes. 1999; 48: 1850-5.
16. Kamchonwongpaisan S, Chandra-ngam G, Avery MA, Yuthavong Y. Resistance to artemisinin of malaria parasites (Plasmodium falciparum) infecting alpha-thalassemic erythrocytes in vitro. Competition in drug accumulation with uninfected erythrocytes. J Clin Invest 1994; 93: 467-73.
17. Kehrer JP, Lund LG. Cellular reducing equivalents and oxidative stress. Free Radic Biol Med 1994; 17: 65-75.
18. Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 1979; 65: 418-20.
19. Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat liver. Biocheml Biophys Res Commun 1976; 71: 952-8.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-75.
21. Meshnick SR. Artemisinin antimalarials: mechanisms of action and resistance. Med Trop 1998; 58: 13-7.
22. Mohan K, Dubey ML, Ganguly NK, Mahajan RC. Plasmodium falciparum induced perturbations of the erythrocyte antioxidant system. Clin Chim Acta 1992; 209:1/2 19-26.
23. Mukanganyama S, Naik YS, Widersten M, Mannervik B, Hasler JA. Proposed reductive metabolism of artemisinin by glutathione transferases in vitro. Free Radic Res 2001; 35: 427-34.
24. Olliaro PL, Haynes RK, Meunier B, Yuthavong Y. Possible modes of action of the artemisinin-type compounds. Trends Parasitol 2001; 17: 122-6.
25. Pandey AV, Tekwani BL, Singh RL, Chauhan VS. Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite. J Biol Chem 1999; 274: 19383-8.
26. Smith SL, Sadler CJ, Dodd CC, et al. The role of glutathione in the neurotoxicity of artemisinin derivatives in vitro. Biochem Pharmacol 2001; 61: 409-16.
27. Spitz DR, Oberley LW. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 1989; 179: 8-18.
28. Srivastava SK, Beutler E. The transport of oxidized glutathione from human erythrocytes. J Biol Chem 1989; 244: 9-16.
29. Trager W, Jensen JB, Cultivation of malarial parasite. Nature 1976; 273: 261-2.
30. Viroonudomphol D, Pongpaew P, Tungtrongchitr R, et al. Erythrocyte antioxidant enzymes and blood pressure in relation to overweight and obese Thai in Bangkok. Southeast Asian J Trop Med Public Health 2000; 31: 325-34.